Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 17.48% and Operating profit at 9.59% over the last 5 years
2
Flat results in Mar 26
3
With ROE of 9.91%, it has a very attractive valuation with a 1.60 Price to Book Value
4
Market Beating performance in long term as well as near term
Stock DNA
Chemicals & Petrochemicals
CNY 9,049 Million (Mid Cap)
22.00
NA
1.14%
0.46
9.91%
1.82
Revenue and Profits:
Net Sales:
1,592 Million
(Quarterly Results - Mar 2026)
Net Profit:
123 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.29%
0%
-2.29%
6 Months
-6.62%
0%
-6.62%
1 Year
28.42%
0%
28.42%
2 Years
76.72%
0%
76.72%
3 Years
7.98%
0%
7.98%
4 Years
-8.86%
0%
-8.86%
5 Years
14.15%
0%
14.15%
Rianlon Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.48%
EBIT Growth (5y)
9.59%
EBIT to Interest (avg)
10.81
Debt to EBITDA (avg)
2.30
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.72
Tax Ratio
11.96%
Dividend Payout Ratio
20.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.13%
ROE (avg)
12.40%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
2.19
EV to EBIT
21.11
EV to EBITDA
14.33
EV to Capital Employed
1.82
EV to Sales
2.14
PEG Ratio
1.16
Dividend Yield
0.95%
ROCE (Latest)
8.62%
ROE (Latest)
9.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,592.20
1,513.70
5.19%
Operating Profit (PBDIT) excl Other Income
180.30
211.00
-14.55%
Interest
13.20
16.70
-20.96%
Exceptional Items
0.20
0.20
Consolidate Net Profit
123.40
91.60
34.72%
Operating Profit Margin (Excl OI)
113.20%
74.70%
3.85%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 5.19% vs -0.03% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 34.72% vs -38.07% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
6,008.10
5,645.10
6.43%
Operating Profit (PBDIT) excl Other Income
975.80
831.50
17.35%
Interest
68.30
65.30
4.59%
Exceptional Items
0.90
1.50
-40.00%
Consolidate Net Profit
473.50
414.20
14.32%
Operating Profit Margin (Excl OI)
96.90%
83.20%
1.37%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 6.43% vs 7.25% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 14.32% vs 15.86% in Dec 2024
About Rianlon Corp. 
Rianlon Corp.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






